Patients remained in the cohort (n=17) Patients lost to follow up (n=11) p-value
Demographic characteristics      
Race      
African American 10 (59%) 5 (46%) 0.80
Hispanic 4 (23%) 3 (27%)  
Caucasian 2 (12%) 3 (27%)  
Asian 1 (6%) 0 (0%)  
Gender      
Male 12 (71%) 6 (55%) 0.44
Female 5 (29%) 5 (45%)  
Drug Screen/Drug Use      
Positive 7 (41%) 4 (40%) 1.00
Age (yr)      
Baseline laboratory tests      
CD4 (cells/uL) 147.2 (134.9) 145 (147.5) 0.97
CD4 percent 10.29 (8.46) 10.55 (8.35) 0.94
Log VL (copies/ml) 5.00 (0.70) 5.28 (0.70) 0.30
Total Cholesterol (mg/dL) 179.7 (51.04) 173.3 (57.31) 0.76
Triglycerides (mg/dL) 138.3 (77.11) 133.9 (55.3) 0.87
HDL (mg/dL) 46.56 (11.85) 38.73 (13.36) 0.12
LDL (mg/dL) 105.6 (53.08) 107.8 (52.12) 0.91
IL-6 7.27 (9.45) 21.55 (30.04) 0.15
Homocysteine (units) 9.94 (2.89) 10.17 (3.42) 0.84
Changes in laboratory values between baseline and week 48
Table 4: Demographics and laboratory values for those that remained and those that were lost to follow up.